CRH Medical (TSE:CRH) had its price objective lifted by research analysts at Royal Bank of Canada from C$5.50 to C$6.50 in a report released on Wednesday, BayStreet.CA reports. The firm presently has an “outperform” rating on the stock. Royal Bank of Canada’s price objective suggests a potential upside of 13.84% from the stock’s current price.
Separately, National Bank Financial boosted their price target on shares of CRH Medical from C$5.75 to C$6.25 and gave the stock an “outperform” rating in a report on Monday.
Shares of TSE:CRH traded up C$0.20 during midday trading on Wednesday, reaching C$5.71. The company had a trading volume of 413,291 shares, compared to its average volume of 138,798. The company’s 50 day moving average price is C$5.01 and its 200 day moving average price is C$4.27. The company has a current ratio of 2.83, a quick ratio of 2.74 and a debt-to-equity ratio of 57.85. The stock has a market cap of $416.25 million and a P/E ratio of 98.45. CRH Medical has a 52-week low of C$3.37 and a 52-week high of C$5.90.
CRH Medical (TSE:CRH) last issued its quarterly earnings results on Thursday, November 7th. The company reported C$0.02 earnings per share for the quarter, topping the Zacks’ consensus estimate of C($0.01) by C$0.03. The company had revenue of C$40.15 million during the quarter, compared to analysts’ expectations of C$41.71 million. Research analysts forecast that CRH Medical will post 0.14 EPS for the current fiscal year.
About CRH Medical
CRH Medical Corporation provides various products and services to gastroenterologists in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid. The company also offers anesthesia services for patients undergoing endoscopic procedures.
Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.